Merck's stock rose 2% Monday on the back of positive data from a study of a new hypertension drug. MRK stock has declined 7% so far this year, compared to a 5.7% increase for the wider pharmaceutical ...

Shares of Novo Nordisk NVO lost 5.5% on Friday after the company announced top-line data from a mid-stage study evaluating the safety and efficacy of its investigational candidate, monlunabant ...

Financial markets are reacting not just to Donald Trump's return to the White House but also to the unpredictability of this victory, according to a new study from the University of Surrey. Investors ...

Pliant Therapeutics (NASDAQ:PLRX) stock jumped 28% on Thursday after the company issued an update for a Phase 2b clinical ...